生长发育第一股!今日,维升药业正式登陆港交所

Insight数据库
21 Mar

3 月 21 日,维升药业正式在香港联交所上市,成为港股市场生长发育第一股,摩根士丹利和杰富瑞(Jefferies)担任联席保荐人,IPO 发行定价为 68.80 港元/股,发行市值 77.06 亿港元。招股书显示,维升药业计划将募资额的 84% 用于核心产品隆培促生长素的 BLA 注册、新适应症拓展和商业化上市工作中,7.6% 用于帕罗培特立帕肽的中国 III 期关键性试验及商业化上市的筹备中。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10